Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

COVID-19 Respiratory Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Xinlun Tian, Dr.) · tianxl@pumch.cn · 8601069155154
Contact: Principal Investigator (Mengzhao Wang)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses

COVID-19 · SARS-CoV-2 Infection

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · San Francisco, United States

Immunosuppression and COVID-19 Boosters

COVID-19

Abroad (travel likely)RecruitingPHASE3

Blacktown, Australia · Camperdown, Australia

REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19

COVID-19 · Critical Illness · ICU Acquired Weakness

Abroad (travel likely)Recruiting

Birmingham, United States · Lexington, United States

COVID-19 Immunity and Changes Over Time

COVID-19

Abroad (travel likely)Recruiting

Hong Kong, China